Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
The development and design of immune-based strategies have become an increasingly important topic during the last few years in acute myeloid leukemia (AML), based on successful immunotherapies in solid cancer. The spectrum ranges from antibody drug conjugates, immune checkpoint inhibitors blocking p...
Main Authors: | Matthias Böhme, Sabine Kayser |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/1/105 |
Similar Items
-
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
by: Mingxue Fan, et al.
Published: (2017-08-01) -
Chimeric antigen receptor T-cell therapy in the treatment of acute myeloid leukemia: Possible challenges
by: Rahul Jagdishchandra Mittal, et al.
Published: (2021-01-01) -
Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
by: Jennifer Marvin-Peek, et al.
Published: (2022-01-01) -
CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2019-01-01) -
CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2018-01-01)